Stockscreener 앱 받기
801.53
0.16%
-1.2988
Lilly Eli Co 주식(LLY)의 최신 뉴스
BofA Securities Maintains Eli Lilly and Co(LLY.US) With Buy Rating - 富途牛牛
Eli Lilly stock price target raised to $930 by BMO on incretin growth - Investing.com
Rumors of Eli Lilly buyout sends Nektar’s shares spiking - PharmaLive
Weight Loss Drugs Market Set to Reach USD 50.26 Billion by 2032, Driven by Prescription Drug Adoption and Breakthrough Formulations – SNS Insider - GlobeNewswire Inc.
Eli Lilly reports positive Phase 3 results for orforglipron in type 2 diabetes trials - Express Pharma
Anti-aging biotech NewLimit brings in Eli Lilly as investor, raising $45M - Endpoints News
J.L. Bainbridge Buys $45 Million in Eli Lilly Stock Despite Price-Pressure Fears - The Motley Fool
Why Eli Lilly and Company stock remains on buy lists2025 Key Highlights & Trade Opportunity Analysis - nchmf.gov.vn
Can Eli Lilly and Company stock surprise with quarterly resultsTrade Volume Report & Weekly High Return Stock Forecasts - nchmf.gov.vn
Can Eli Lilly and Company (LLY) stock reach $200 price targetNew Guidance & Target Return Focused Stock Picks - nchmf.gov.vn
Major Stock Moves: Eli Lilly, Delta, Caterpillar, Dell, CoreWeave - TipRanks
Can Eli Lilly and Company stock withstand economic slowdownJuly 2025 Levels & Fast Entry and Exit Trade Plans - nchmf.gov.vn
3 Price Catalysts For Eli Lilly (NYSE:LLY) - Seeking Alpha
Eli Lilly (LLY) Reports Positive Results from Breast Cancer Trial - TipRanks
Stock Movers: Oracle, American Express, Eli Lilly - Bloomberg
Why Eli Lilly (LLY) Stock Is Down Today - Yahoo Finance
Eli Lilly (LLY) Shares Drop Due to Recent Voucher Snub and Compe - GuruFocus
Eli Lilly falls on orforglipron FDA voucher exclusion, Trump on weight-loss meds - Seeking Alpha
Here's What Trump Said That's Pressuring Novo Nordisk and Eli Lilly Stocks - MSN
Eli Lilly Shares Are Trading Lower Friday: What's Going On? - Benzinga
Novo, Lilly Fall as Trump Touts ‘Much Lower’ Ozempic Price - Bloomberg
Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs? - Benzinga
Market Jitters: Dow Dips Amid Bank Fears While Eli Lilly and Novo Nordisk Tumble on Trump's Drug Pricing Comments - FinancialContent
Novo, Lilly Shares Drop as Trump Promises $150 Ozempic - BioSpace
Trump says Ozempic will get cheaper. Novo Nordisk, Eli Lilly stock slump - Yahoo Finance
Lilly CSO defends hiring of ex-FDA chief Peter Marks - statnews.com
Eli Lilly, Novo Nordisk Tumbles After Trump Says Weight-Loss Drugs Are 'Too Expensive' - Yahoo
Novo Nordisk, Eli Lilly shares drop as Trump promises lower weight loss drug prices - Proactive financial news
Eli Lilly (LLY) Reports Promising Results from Phase 3 monarchE Trial - GuruFocus
Eli Lilly Sets Ambitious Sustainability Goals Despite Headwinds - Investor's Business Daily
Cantor Fitzgerald maintains Eli Lilly stock rating despite orforglipron setback - Investing.com
Novo Nordisk, Eli Lilly shares drop as Trump vows weight-loss drug price cuts - Yahoo
Eli Lilly Says Verzenio Reduced Risk of Death In Late-Stage Trial In Some Breast Cancer Patients - Stocktwits
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics - sharewise.com
Eli Lilly reports results from Phase 3 monarchE trial - TipRanks
Eli Lilly Makes A Bold Claim For Its Biggest Cancer Drug - Investor's Business Daily
Lilly, Novo Slide as Trump Touts 'Much Lower' Ozempic Price - MarketScreener
Novo Nordisk (NVO) and Eli Lilly (LLY): Weight-Loss Drug Stocks Dip on Trump’s New Price Promise - TipRanks
Analyst recommendations: Moody's, Broadcom, Eli Lilly, Micron Technology, Tesla… - MarketScreener
Trump's Drug Price Pledge Slams Eli Lilly Stock - Value The Markets
Goldman Sachs AM Wins Eli Lilly $25bn OCIO Mandate - Markets Media
Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street? - The Motley Fool
Eli Lilly Stock Moves Lower Despite Analyst’s Bullish Stance - AskTraders.com
Lilly, Novo shares fall after Trump touts ‘much lower’ price of Ozempic - Al Arabiya English
Eli Lilly, Novo Nordisk Stocks Fall After-Hours As Trump Pledges Swift Price Cuts For ‘Fat-Loss Drugs’ - MSN
Eli Lilly taps Goldman Sachs as OCIO - Alternatives Watch
Eli Lilly (LLY) Retains Positive Outlook Despite Drug Selection Exclusion - GuruFocus
Eli Lilly’s Stock Surges Amid Mixed Signals - TipRanks
Eli Lilly (LLY) Sees Decline After Trump's Comments on Drug Pric - GuruFocus
Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs' - Benzinga
Eli Lilly (LLY) Shares Drop 3% Following Recent Remarks - GuruFocus
Lilly confirms date and conference call for third-quarter 2025 financial results announcement - Investing News Network
Is Eli Lilly Stock A Buy After Surging On Trump's Drug-Pricing Plans? - Investor's Business Daily
Chesapeake Sells 9,900 Eli Lilly (LLY) Shares Worth $7.7 Million - The Motley Fool
Eli Lilly’s Latest Study on Obesity Treatment: A Promising Update - TipRanks
Eli Lilly and Cipla’s Diabetes Study: A Market Game Changer? - TipRanks
Lilly’s Orforglipron Bests Farxiga In Type 2 Diabetes Head-to-Head - insights.citeline.com
Eli Lilly and Co. Selects Goldman Sachs for $25B OCIO Mandate - ai-cio.com
Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2025 financial results on October 30, 2025. - Somos Hermanos -
Oct. 30 conference call at 10 a.m. ET — Eli Lilly to announce third-quarter results; webcast available - Stock Titan
Eli Lilly (LLY) Robust "Buy" Rating Reaffirmed by Guggenheim | L - GuruFocus
Guggenheim Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $948 - 富途牛牛
Here's What To Expect From Eli Lilly’s Next Earnings Report - Barchart.com
Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly? - The Motley Fool
0.00%
자본화:
|
볼륨(24시간):